Selected article for: "acute respiratory distress and long term acute"
Author: Vasarmidi, Eirini; Tsitoura, Eliza; Spandidos, Demetrios A.; Tzanakis, Nikolaos; Antoniou, Katerina M.
Title: Pulmonary fibrosis in the aftermath of the COVID-19 era (Review)
  • Cord-id: ixvsemvw
  • Document date: 2020_7_9
    • ID: ixvsemvw
    Snippet: The year 2020 is characterized by the COVID-19 pandemic that has resulted in more than half a million deaths in recent months. The high mortality is associated with acute severe respiratory failure that results in ICU admission and intubation. While facing this fatal disease, research and clinical observations need to be carried out in order to evaluate the long-term effects of the COVID-19 acute respiratory distress syndrome (ARDS). Potent clinical and laboratory biomarkers should be studied to
    Document: The year 2020 is characterized by the COVID-19 pandemic that has resulted in more than half a million deaths in recent months. The high mortality is associated with acute severe respiratory failure that results in ICU admission and intubation. While facing this fatal disease, research and clinical observations need to be carried out in order to evaluate the long-term effects of the COVID-19 acute respiratory distress syndrome (ARDS). Potent clinical and laboratory biomarkers should be studied to be able to predict the subgroup of patients that are going to deteriorate or develop lung fibrosis. The opportunity of personalized medicine is a good way to consider for these patients.

    Search related documents:
    Co phrase search for related documents
    • acceptable safety profile and long term follow: 1
    • acceptable safety profile and lung complication: 1
    • acceptable safety profile and lung disease: 1, 2
    • acute ards respiratory distress syndrome and long term follow: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and long term follow study: 1
    • acute ards respiratory distress syndrome and low expression: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lps induce: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lung capacity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and lung complication: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome develop and long term follow: 1
    • acute ards respiratory distress syndrome develop and lung capacity: 1
    • acute ards respiratory distress syndrome develop and lung damage: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome develop and lung disease: 1, 2, 3
    • acute inflammation and long term follow: 1
    • acute inflammation and long term impairment: 1
    • acute inflammation and low expression: 1, 2
    • acute inflammation and lung capacity: 1, 2